PHILADELPHIA, Oct. 18, 2017 -- Carpenter Technology Corporation (NYSE:CRS) plans to host a conference call and webcast on Thursday, October 26, 2017 at 10:00 a.m. ET to discuss the results of operations for the first quarter of fiscal 2018, ended September 30, 2017. The call and webcast will follow the release of first quarter fiscal 2018 financial results before the market opens on Thursday, October 26, 2017.
Conference Call and Webcast Details
What: Carpenter Technology First Quarter Fiscal 2018 Conference Call
Date: Thursday, October 26, 2017
Time: 10:00 a.m. Eastern Time
Live Call: +1 412-317-9259
Live and Archived Webcast: www.cartech.com
About Carpenter Technology
Carpenter Technology Corporation is a leading producer and distributor of premium specialty alloys, including titanium alloys, nickel and cobalt based superalloys, stainless steels, alloy steels and tool steels. Carpenter’s high-performance materials and advanced process solutions are an integral part of critical applications used within the aerospace, transportation, medical and energy markets, among other markets. Building on its history of innovation, Carpenter’s powder technology capabilities support a range of next-generation products and manufacturing techniques, including additive manufacturing and 3D Printing. Information about Carpenter can be found at www.cartech.com.
Media Inquiries:
William J. Rudolph, Jr.
+1 610-208-3892
[email protected]
Investor Inquiries:
Brainerd Communicators
Brad Edwards
+1 212-986-6667
[email protected]


Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



